Search results for "Trombosi"

showing 10 items of 32 documents

Prueba de Homans

2010

La prueba de Homans se realiza previamente a la aplicación de diferentes técnicas fisioterapias que presentan como contraindicación la presencia de trombosis venosa profunda.

3213.11 Ciències MédiquesFisioterapiaexploración clínicainsuficiencia venosaprueba de Homanstrombosis venosa profundaFisioterapia3213.11- Farmacia Medicina
researchProduct

Prevención de la trombosis venosa profunda

2010

Entre las medidas profilácticas que se pautan en la trombosis venosa profunda, encontramos la asistencia venosa intermitente. Se trata de un dispositivo de compresión neumática que simula las presiones sobre la bóveda plantar durante la deambulación.

3213.11 Ciències MédiquesFisioterapiatrombosis venosa profundaprevencióndecúbitoFisioterapia3213.11- Farmacia Medicina
researchProduct

Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis.

2007

It is not well established whether haemorheological alterations constitute independent risk factors for deep vein thrombosis (DVT).We have determined in 149 DVT patients and in 185 control subjects the body mass index (BMI), the haemorheological profile: blood viscosity (BV), plasma viscosity (PV), fibrinogen (Fg), erythrocyte aggregation (EA), erythrocyte deformability (ED) and plasma lipids. In the crude analysis BMI, Fg, PV, EA, triglycerides (TG) and ApoB were statistically higher and HDL cholesterol (HDL-Chol) statistically lower in DVT patients than in controls. No differences in BV and ED were observed.After BMI adjustment, Fg, PV and EA remained statistically higher in DVT cases tha…

AdultErythrocyte AggregationMalemedicine.medical_specialtyTime FactorsDeep veinBlood viscosityHyperlipidemiasFibrinogenGastroenterologyRisk AssessmentBody Mass IndexDeep vein thrombosis; Lipids; Obesity; HaemorheologyRisk FactorsInternal medicineDeep vein thrombosisErythrocyte DeformabilityOdds RatioMedicineHumanscardiovascular diseasesObesityRisk factorTriglyceridesUNESCO::CIENCIAS MÉDICAS ::Patología::TrombosisVenous Thrombosisbusiness.industryFibrinogenHematologyOdds ratioMiddle Agedmedicine.diseaseBlood ViscosityThrombosisLipidsSurgeryHaemorheologymedicine.anatomical_structureCholesterolCase-Control StudiesHemorheologyHemorheologyFemalebusinessBody mass index:CIENCIAS MÉDICAS ::Patología::Trombosis [UNESCO]medicine.drugThrombosis and haemostasis
researchProduct

Utilidad de la ecografía Doppler infrapoplítea en pacientes con sospecha de enfermedad tromboembólica venosa

2017

La enfermedad tromboembólica venosa (ETEV) es una enfermedad vascular compleja con una patogénesis multifactorial. Su importancia radica en su alta prevalencia y en la morbimortalidad asociada. Agrupa dos presentaciones clínicas mayores, la más frecuente es la trombosis venosa profunda (TVP) y la más temida por su riesgo de mortalidad es el tromboembolismo pulmonar (TEP). Se identifican principalmente dos localizaciones de TVP en los miembros inferiores (MMII): la trombosis proximal (TP) cuando afecta a las venas profundas del hueco poplíteo y proximales a éste, y la trombosis distal cuando afecta a las venas profundas y musculares de la pantorrilla. La trombosis distal puede darse de forma…

InfrapoplíteoDoppler:CIENCIAS MÉDICAS ::Ciencias clínicas::Radiología [UNESCO]EcografíaUNESCO::CIENCIAS MÉDICAS ::Patología::HematologíaUNESCO::CIENCIAS MÉDICAS ::Ciencias clínicas::Radiología:CIENCIAS MÉDICAS ::Patología::Hematología [UNESCO]Trombosis venosa profundaTrombosis distal aislada
researchProduct

Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.

2016

Venous thromboembolism (VTE) is common in cancer patients. However, little is known about VTE risk in metastatic urothelial carcinoma or variant histologies (UC/VH). We sought to characterize the incidence, associative factors, including whether various chemotherapy regimens portend different risk, and impact of VTE on survival in metastatic UC/VH patients. Patients diagnosed with metastatic UC/VH from 2000 to 2013 were included in this multicenter retrospective, international study from 29 academic institutions. Cumulative and 6-month VTE incidence rates were determined. The association of first-line chemotherapy (divided into six groups) and other baseline characteristics on VTE were anal…

MaleOncologyCancer Researchmedicine.medical_treatmentDisease030204 cardiovascular system & hematologyDeoxycytidine0302 clinical medicineNeoplasm MetastasisOriginal ResearchIncidenceIncidence (epidemiology)Middle AgedPrognosis3. Good healthOncology030220 oncology & carcinogenesischemotherapy survivalbladder cancerFemaleBufeta -- Càncermedicine.drugAdultmedicine.medical_specialtyMetastatic Urothelial Carcinomavenous thromboembolismAntineoplastic Agents[SDV.CAN]Life Sciences [q-bio]/Cancer03 medical and health sciencesInternal medicineUrothelialmedicineHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesAgedRetrospective StudiesTrombosi -- TractamentGynecologyCisplatinCarcinoma Transitional CellChemotherapyBladder cancerbusiness.industryClinical Cancer ResearchCancermedicine.diseaseequipment and suppliesSurvival AnalysisGemcitabineGemcitabineUrinary Bladder NeoplasmsUrothelial;Cisplatinbusiness
researchProduct

Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors

2017

Data de publicació electrónica: 24-08-2017 BACKGROUND: Venous thromboembolism (VTE) is common in cancer patients, but there is limited data on patients with urothelial tract tumors (UTT). We previously identified several associative factors for increased VTE rates in patients with metastatic UTT. In this study, we assessed the frequency, associative factors, and impact on survival of VTE in patients with locoregional UTT. METHODS: Patients with locoregional bladder, upper urinary tract, or urethral cancer were included in this multi-center study from 29 academic institutions. Patients with N1, or M1 disease at diagnosis were excluded. Patients with incomplete clinical staging or miscoded/mi…

Oncologymedicine.medical_specialtyMultivariate analysisUrology[SDV.CAN]Life Sciences [q-bio]/CancerDiseaseLogistic regression[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health sciences0302 clinical medicineInternal medicinemedicineTrombosi030212 general & internal medicinecardiovascular diseasesUrethral cancerBladder cancerbusiness.industryIncidence (epidemiology)Bladder cancerNon-urothelialCancerThrombosisLocalizedmedicine.diseaseThrombosis3. Good healthOncology030220 oncology & carcinogenesisMetastaticBufeta -- Càncerbusiness
researchProduct

Trombosi portale mesenterica idiopatica in paziente con doppia mutazione eterozigote del gene C677T e del gene A1298C della MTHFR

2002

Settore MED/09 - Medicina InternaTrombosi mesenterica idiopatica gene C677T gene A1298C MTHFR
researchProduct

Ottimizzazione delle tecniche di imaging per lo studio ed il monitoraggio delle lesioni epatiche in pazienti con malattie vascolari del fegato.

2014

Settore MED/36 - Diagnostica Per Immagini E Radioterapialesioni epatiche Sindrome di Budd-Chiari Sindrome di Rendu-Osler-Weber Teleangiectasia emorragica ereditaria Trombosi della vena porta Cavernomatosi portale e trasformazione cavernosa della vena porta.
researchProduct

INSIDIE DIAGNOSTICHE DELLA TROMBOSI VENOSA CEREBRALE: STORIA DI UN CASO CLINICO

2018

Introduzione: la trombosi venosa cerebrale (TVC) è una condizione rara, le manifestazioni sono spesso elusive, i primi reperti radiologici non d‘immediato riscontro e quindi trascurabili. La prognosi neurologica è variabile ma nell'80% dei casi è favorevole. Incidenza: 7 bambini milione/anno. Clinica: cefalea improvvisa, convulsioni, coma, alterazioni oculari i più frequenti. I fattori di rischio, in accordo con la triade di Virchow: trombofilia congenita o acquisita, danno endoteliale (es: flogosi, infezioni) e stasi del flusso sanguigno (es: policitemia). Diagnosi: anamnesi, esame obiettivo, Rm cerebrale, in alternativa eseguire la TC encefalo, se queste negative può essere utile un'angio…

Settore MED/38 - Pediatria Generale E SpecialisticaTROMBOSI VENOSA CEREBRALE AUTISMOALTERAZIONI NEUROLOGICHE
researchProduct

TROMBOSI VENOSA PROFONDA DA ESTROPROGESTINICI IN TETRASOMIA X

2009

Trombosi venosa profonda Tetrasomia X EstroprogestiniciSettore MED/38 - Pediatria Generale E Specialistica
researchProduct